Yüksel Ürün, Professor of Medical Oncology at Ankara University, shared on X:
“Urine cfRNA is emerging as a powerful bladder cancer biomarker:
95% sensitivity at 90% specificity, with potential for MRD detection and BCG-response prediction. Prospective validation comes next.”
Title: Urine cell-free RNA for bladder cancer detection and treatment response prediction
Authors: Kevin J. Liu, William Y. Shi, Monica C. Nesselbush, Nick A. Phillips, Kathleen E. Mach, Bogdan Luca, Ravi K. Bajpai, Isabel Jabara, Jordan C. Cheng, Takeshi Sugio, Navika Shukla, Emily C. Shen, Ivy Lee Koh, Douglas J. Wu, Chih-Long Liu, Diego Almanza, Soyeong Jun, Feng Tian, Emily G. Hamilton, Christian R. Hoerner, Rui Wang, Mohammad S. Esfahani, Angela Hui, Vinh La, Grace Holton, Gabriela Rodriguez, Timothy J. Lee, Xi Ling, Nikitha Kalahasti, Spoorthi Vallamkonda, Patrick Mullane, Simon B. Chen, Eugene Shkolyar, Kris Prado, Ali Raza Khaki, Emily Chan, Mark K. Buyyounouski, Alice C. Fan, Eila C. Skinner, Ash A. Alizadeh, Joseph C. Liao, Maximilian Diehn
You can also read: Imugene Reports New Responses With Azercabtagene Zapreleucel Plus BTK Inhibitor in Phase 1b Blood Cancer Trial
